课题基金 / 基金详情

Development the new cancer treatment targeting the regulation system of cancer stem cells

Development the new cancer treatment targeting the regulation system of cancer stem cells
针对癌症干细胞调控系统开发新的癌症治疗方法
批准号:
18390350
负责人:
NAKAMURA Masafumi
金额:
$10.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

NAKAMURA Masafumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
(Purpose) Cancer stem cell (CSC), characterized by the ability of multi-drug resistance, assumed as outbreak source to create heterogeneity of cancer cells. The purpose of this research is to elucidate the mechanism of maintaining CSC and to establish control method for CSC.(Materials and a methods) With breast cancer and colo-rectal cancer cell strains, we examined the number of CSCs in the strains under the different activation state of the various morphogen signals and anticancer agents. CSCs were purified based on the intensity of Hoechst 33342 staining (SP (side population)) or CD24-/lowCD44+ expression. We analyzed activity of the morphogen signals in CSC. We also checked the significance of morphogen signals on CSC growth. Next we examined influence of DAPT, suppressor of assumed colo-rectal CSC factor Notch signal, on sensitivity of anti-cancer agent. Furthermore, we inspected the effect of antibodies raised against Patched1, receptor of Hedgehog signaling pathway, on CSC growt … More h.(Results) We succeeded in the detection and purification of SP fraction and CD24-/low CD44+ fraction of breast cancer cell strain. These two CSC fractions, SP fraction and CD24-/low CD44+ fraction, shared major population and had the drug resistant ability. Gli1, trancactivator of the Hedgehog (Hh) signaling pathway, was up-regulated in both CSC fractions. Down-regulation of the Hh signaling activity reduced the ratio of the CSC fractions of the whole all cell counts. Meanwhile, Hh signaling pathway, supposed CSC factor, was activated by ER, a landmark of the breast cell differentiation. The significance of this complicated role of Hh signaling pathway in both cancer stem cells and differentiated cancer cells has to be further examined. DAPT, the suppressor of Y-secretase inhibitor and the Notch signal, increased the sensitivity of colo-rectal cancer cells to the anti-cancer agent. Further examination revealed that this anti-cancer ability of DAPT is unrelated to Notch, and may be involved in APC status.(Conclusion) Hh signaling pathway may be essential for the maintenance of breast CSC. DAPT suppressed the drag resistance ability of colorectal cancer and the target of DAPT may give clues to elucidate the maintenance system of colorectal CSC. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
大腸癌に対する腫瘍幹細胞療法開発の可能性
开发结直肠癌肿瘤干细胞疗法的可能性
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [近沢 信人、中村 雅史, 他]
通讯作者:
Gamma-secretase inhibitors enhance taxane-induced mitotic arrest andapoptosis in colon cancer cells
γ-分泌酶抑制剂增强紫杉烷诱导的结肠癌细胞有丝分裂停滞和细胞凋亡
DOI: --
发表时间: 2008
期刊: Gastroenterology 134
影响因子: --
作者: [Akiyoshi T., Nakamura M., et. al.]
通讯作者: et. al.
腫瘍幹細胞cancer stem cellを標的とした乳癌治療法の開発
针对癌症干细胞的乳腺癌治疗的发展
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [田中晴生, 中村雅史, 宗崎正恵, 甲斐昌也, 亀田千津, 久保真, 田中雅夫, 片野光男]
通讯作者: 片野光男
A Novel Link Between Estrogen Receptor a and the HedgehogPathway in Breast Cancer
雌激素受体 a 与乳腺癌 Hedgehog 通路之间的新联系
DOI: --
发表时间: 2008
期刊: Anticancer research (in press)
影响因子: --
作者: [Koga K, Nakamura M., et. al.]
通讯作者: et. al.
8
    Analysis and remodeling of immune microenvironment using pancreatic cancer organoids after treatment
    • 批准号:
      21K19531
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.16万
    • 财政年份:
      2021
    • 负责人:
      NAKAMURA Masafumi
    • 依托单位:
    Elucidation of the intratumor therapeutic resistance heterogeneity using single-cell transcriptome of the PDX libraries with pancreatic cancer.
    • 批准号:
      19H03732
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2019
    • 负责人:
      NAKAMURA Masafumi
    • 依托单位:
    Elucidation and control of the mechanism of cluster invasion by partialEMT using pancreatic cancer organoids
    • 批准号:
      19K22663
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.16万
    • 财政年份:
      2019
    • 负责人:
      NAKAMURA Masafumi
    • 依托单位:
    Novel method to visualize invasion and metastasis of pancreatic cancer using in vitro microenvironment model constructed by 3D bioprinter
    • 批准号:
      17K19605
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.16万
    • 财政年份:
      2017
    • 负责人:
      NAKAMURA Masafumi
    • 依托单位:
    海外基金